References
1. Bokeriya L.A., Muratov R.M., Babenko S.I., Soboleva N.N., Semenova E.V. New frameless xenopericardial prosthesis «BioLAB» in aortic valve surgery. Thoracic and Cardiovascular Surgery. 2015; 57 (1): 25–31. (in Russian)
2. Barbarash L.S., Karas’kov A.M., Semenovsky M.L., Zhuravleva I.Yu., Odarenko Yu.N., Vavilov P.A., et al. Bioprostheses of heart valves in Russia: experience of three clinics. Pathology of Blood Circulation and Cardiac Surgery. 2011; (2): 21–6. (in Russian)
3. David T.E., Armstrong S., Maganti M. Hancock II bioprosthesis for aortic valve replacement: the gold standard of bioprosthetic valves durability? Ann Thorac Surg. 2010; 90 (3): 775–81. DOI: https://doi.org/10.1016/j.athoracsur.2010.05.034
4. Belov Yu.V., Charchyan E.R., Katkov A.I., Salagaev G.I., Vinokurov I.A. Influence of discrepancy between the diameter of the prosthesis and the surface area of the patient's body on the long-term results of aortic valve replacement. Cardiology and cardiovascular surgery. 2016;9(2):46-51. (In Russ.) https://doi.org/10.17116/kardio20169246-51
5. Khalpey Z., Myers P.O., McGurk S., Schmitto J.D., Nauta F., Borstlap W., et al. Nineteen-millimeter bioprosthetic aortic valves are safe and effective for elderly patients with aortic stenosis. Ann Thorac Surg. 2016; 101 (2): 650–7. DOI: https://doi.org/10.1016/j.athoracsur.2015.07.081
6. Ozaki S., Kawase I., Yamashita H., Uchida S., Nozawa Y., Takatoh M., et al. A total of 404 cases of aortic valve reconstruction with glutaraldehyde-treated autologous pericardium. J Thorac Cardiovasc Surg. 2014; 147 (1): 301–6. DOI: https://doi.org/10.1016/j.jtcvs.2012.11.012
7. Vahanian A., Beyersdorf F., Praz F., Milojevic M., Baldus S., Bauersachs J., et al. 2021 ESC/EACTS Guidelines for the management of valvular heart disease: developed by the Task Force for the management of valvular heart disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS). Eur Heart J. 2022; 43 (7): 561–632. DOI: https://doi.org/10.1093/eurheartj/ehab395
8. Pibarot P., Dumesnil J.G. Prosthesis-patient mismatch: definition, clinical impact, and prevention. Heart. 2006; 92 (8): 1022–9. DOI: http://dx.doi.org/10.1136/hrt.2005.067363
9. Bridgewater B., Gummert J., Kinsman R. Fourth EACTS adult cardiac database individual country report for England. Henley-on-Thames : EACTS, 2010: 24 p.
10. Vitanova K., Wirth F., Boehm J., Burri M., Lange R., Krane M. Surgical aortic valve replacement-age-dependent choice of prosthesis type. J Clin Med. 2021; 10 (23): 5554. DOI: https://doi.org/10.3390/jcm10235554
11. Freitas-Ferraz A.B., Tirado-Conte G., Dagenais F., Ruel M., Al-Atassi T., Dumont E., et al. Aortic stenosis and small aortic annulus: clinical challenges and current therapeutic alternatives. Circulation. 2019; 139 (23): 2685–702. DOI: https://doi.org/10.1161/CIRCULATIONAHA.118.038408
12. Hoffmann G., Ogbamicael S.A., Jochens A., Frank D., Lutter G., Cremer J., et al. Impact of patient-prosthesis mismatch following aortic valve replacement on short-term survival: A retrospective single center analysis of 632 consecutive patients with isolated stented biological aortic valve replacement. Thorac Cardiovasc Surg. 2014; 62 (6): 469–74. DOI: https://doi.org/10.1055/s-0033-1363498
13. Lim W.Y., Lloyd G., Bhattacharyya S. Mechanical and surgical bioprosthetic valve thrombosis. Heart. 2017; 103 (24): 1934–41. DOI: https://doi.org/10.1136/heartjnl-2017-311856
14. Murashita T., Okada Y., Kanemitsu H.H., Fukunaga N., Konishi Y., Nakamura K., et al. Efficacy of stentless aortic bio-prosthesis implantation for aortic stenosis with small aortic annulus. Thorac Cardiovasc Surg. 2015; 63 (6): 446–51. DOI: https://doi.org/10.1055/s-0034-1389106
15. Suri R.M., Michelena H.I., Burkhart H.M., Greason K.L., Daly R.C., Dearani J.A., et al. A prospective, randomized comparison of 3 contemporary bioprosthetic aortic valves: should hemodynamic performance influence device selection? J Thorac Cardiovasc Surg. 2012; 144 (6): 1387–98. DOI: https://doi.org/10.1016/j.jtcvs.2012.07.105
16. Tasca G., Stefano A., Giannico F., Lobiati E., Riva B., Galanti A., et al. Early hemodynamic evaluation of Trifecta and Freestyle bioprostheses in patients with a small aortic root: preliminary results from a prospective randomized study. J Heart Valve Dis. 2014; 23 (5): 633–41. PMID: 25799714.
17. Gersak B., Fischlein T., Folliguet T.A., Meuris B., Teoh K.H., Moten S.C., et al. Sutureless, rapid deployment valves and stented bioprosthesis in aortic valve replacement: Recommendations of an International Expert Consensus Panel. Eur J Cardiothorac Surg. 2016; 49 (3): 709–18. DOI: https://doi.org/10.1093/ejcts/ezv369
18. Johnston D.R., Soltesz E.G., Vakil N., Rajeswaran J., Roselli E.E., Sabik III J.F., et al. Long-term durability of bioprosthetic aortic valves: implications from 12,569 implants. Ann Thorac Surg. 2015; 99 (4): 1239–47. DOI: https://doi.org/10.1016/j.athoracsur.2014.10.070
19. Astapov D.A., Demidov D.P., Semenova E.I., Zheleznev S.I., Zorina I.G., Syrtseva Ya.V. The first experience of implantation of a xenopericardial prosthesis with a framework of variable rigidity «TiAra» in the aortic position. Pathology of Blood Circulation and Cardiac Surgery. 2013; (2): 73–5. (in Russian)
20. Evtushenko A.V., Stasev A.N., Kokorin S.G., Sotnikov A.V., Dvadtsatov I.V., Barbarash L.S. The first clinical experience of the isolated use of a new generation xenopericardial semi-framed bioprosthesis TiAra. Clinical and experimental surgery. Clinical and Experimental Surgery. The Journal named after B.V. Petrovsky. 2021; 9 (2): 14–20. DOI: https://doi.org/10.33029/2308-1198-2021-9-2-14-20 (in Russian)
21. Moskowitz G., Hong K.N., Giustino G., Gillinov A.M., Ailawadi G., DeRose J.J., et al. Incidence and risk factors for permanent pacemaker implantation following mitral or aortic valve surgery. J Am Coll Cardiol. 2019; 74 (21): 2607–20. DOI: https://doi.org/10.1016/j.jacc.2019.08.1064